Skip to content

Clinical trials

Recruiting Phase 2/3 trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Recruiting Country / region: Taiwan Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20202
20223
20231
20243
202512
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Pfizer4
Bristol-Myers Squibb3
Janssen Research & Development, LLC2
National Taiwan University Hospital2
ACADIA Pharmaceuticals Inc.1
Bicara Therapeutics1
CSL Behring1
Chang Gung Memorial Hospital1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung4
Neoplasms3
Lung Neoplasms2
Neoplasm Metastasis2
Adenoma, Islet Cell1
Anorexia1
Atherosclerosis1
Biliary Tract Neoplasms1
Brain Neoplasms1
Cachexia1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.